Effects of the PCSK9 C378W Mutation on PCSK9 Levels and Lipid Profiles in Taiwanese Individuals: A Loss-of-Function Mutation with Potential Cardiovascular Benefits
<b>Background</b>: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of lipid metabolism. The rare PCSK9 C378W (rs776752113) mutation influences the level of low-density lipoprotein cholesterol (LDL-C); however, its association with PCSK9 levels remain unclear. <b>Methods</b>: This study investigates the frequency of the C378W mutation and its effects on PCSK9 levels and lipid profiles in 5901 Taiwan Biobank participants, including 1486 individuals with available whole-genome sequencing data. The C378W mutations were detected using a TaqMan genotyping assay and confirmed using direct DNA sequencing. <b>Results</b>: Whole-genome sequencing data revealed a single carrier of the C378W mutation. The TaqMan assay identified seven carriers of the 378W allele (7/5901 [0.119%]). After the exclusion of an individual with a history of hyperlipidemia, six carriers exhibited significantly lower levels of LDL-C (-30.5%) and PCSK9 (-56.4%) than noncarriers (LDL-C: 81.17 ± 21.79 vs. 116.70 ± 30.70 mg/dL [<i>p</i> = 0.0005]; PCSK9: 67.20 ± 14.83 vs. 154.02 ± 45.52 ng/mL [<i>p</i> = 3.59 × 10<sup>-12</sup>]. Moreover, carriers exhibited significantly lower levels of total cholesterol (-18.6%) and non-high-density lipoprotein cholesterol (non-HDL-C; -28.4%) than noncarriers (total cholesterol: 157.17 ± 19.30 vs. 193.18 ± 35.22 mg/dL [<i>p</i> = 0.0035]; non-HDL-C: 99.50 ± 20.22 vs. 138.91 ± 34.97 mg/dL [<i>p</i> = 0.0005]). Mediation analysis suggests that the association between the C378W mutation and LDL-C levels persisted even after adjustment for PCSK9 levels. Functional characterization indicates that the C378W mutation impairs protein stability and function. <b>Conclusion</b>: In conclusion, the rare C378W mutation represents a loss-of-function mutation in the Taiwanese population. This variant is independently associated with reduced PCSK9 levels and improved lipid profiles, highlighting its potential cardioprotective role.
Authors
- Yu‐Lin Ko (ORCID: https://orcid.org/0000-0002-8218-6827)
- Lung‐An Hsu (ORCID: https://orcid.org/0000-0002-0012-2804)
- Kun‐Huei Yeh (ORCID: https://orcid.org/0000-0002-7306-174X)
- Semon Wu (ORCID: https://orcid.org/0000-0002-4544-9130)
Institutions
- Chang Gung University (TW)
- Tzu Chi University (TW)
- Chinese Culture University (TW)
- Chang Gung Memorial Hospital (TW)
- Taoyuan Chang Gung Memorial Hospital (TW)
- Taipei Tzu Chi Hospital (TW)
Publication Details
- Journal
- Genes
- Published
- 2025-09-19
- DOI
- https://doi.org/10.3390/genes16091113
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00